Work

Erlotinib as first-line treatment for untreated advance stage NSCLC with good prognosis

Year: 2006

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2006.24.18_suppl.7178

Author: W. L. Akerley

Institution: Huntsman Cancer Institute

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2965845866

Cites:

Cited by: 2

Related to: 10